TG6-44 treatment leads to decrease in A/X31-induced cell death in THP-1 cells. by Juan A. De La Cruz (11154187)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Absence of FumC leads to decreased susceptibility to bactericidal antibiotics. by Stephanie D. Himpsl (8501868)

The effects of NAC on the decreased number of myotube formations caused by arecoline. by Yi-Xuan Li (6633845)

Afatinib decreases MAPK and AKT activation after MET knockdown. by Karolin Ebert (7434713)

Loss of FOXP1 results in decreased number of bRGCs. by Seon Hye E. Park (16765033)

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

Apoptosis inhibitor prevented the decrease of IIL ESP-induced TJs expression and alleviated barrier disruption of Caco-2 monolayer. by Qi Qi Lu (17721401)

Subjects:

Decreasing Structural Dimensionality of Double Perovskites for Phase Stabilization toward Efficient X‑ray Detection by Da Chen (585723)

Decreasing Structural Dimensionality of Double Perovskites for Phase Stabilization toward Efficient X‑ray Detection by Da Chen (585723)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

Overexpressions of the AB domain of RPA70 and the β-barrel domain of Ku70 significantly decrease HBoV1 replication in HAE-ALI. by Kang Ning (59789)

“…Duplex HBoV1 genome was loaded as a size marker (M) of 5.5 kb. …”

Fig 5 - by Rabeya Binta Alam (17364707)

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Flowchart of study patients evaluated for cumulative incidence of decreased GFR estimation. by Camila de Souza dos Santos (17721066)

TBEV infection results in decrease of <i>de novo</i> synthesised 45-47S pre-rRNA. by Martin Selinger (3195987)

CRVE change with 12 months of RFM/CPAP treatment. by Kristina Kairaitis (10535437)

Subjects:

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

rhMG53 decreases membrane damage <i>in vitro</i>. by Brian J. Paleo (8694246)